Low-Cost Anti-HIV Compounds: Potential Application for AIDS Therapy in Developing Countries
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1419-1431
Author(s):
Aldar S. Bourinbaiar and Vichai Jirathitikal
Concurrent Use of Antiretrovirals and Anticonvulsants in Human Immunodeficiency Virus (HIV) Seropositive Patients
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1433-1439
Author(s):
Frank Romanelli and Claire Pomeroy
Highly Active Antiretroviral Therapy and Cardiovascular Complications in HIV-Infected Patients
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1475-1481
Author(s):
Giuseppe Barbaro and Edward C. Klatt
Death Receptor Signaling in Cancer Therapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
253-262
Author(s):
Simone Fulda and Klaus-Michael Debatin
Resistance to Apoptosis: Mechanism for the Development of HIV Reservoirs
Journal:
Current HIV Research
Volume:
1
Page:
261-274
Author(s):
Julian J. Lum and Andrew D. Badley
HIV-1 Replication and Pathogenesis in the Human Thymus
Journal:
Current HIV Research
Volume:
1
Page:
275-285
Author(s):
Eric G. Meissner, Karen M. Duus, Rebecca Loomis, Rhiannon D'Agostin and Lishan Su
HIVs Evasion of Hosts NK Cell Response and Novel Ways of its Countering and Boosting Anti-HIV Immunity
Journal:
Current HIV Research
Volume:
1
Page:
295-307
Author(s):
Ali Ahmad and Rasheed Ahmad
Advances in Vaccine Adjuvants For Infectious Diseases
Journal:
Current HIV Research
Volume:
1
Page:
309-320
Author(s):
Manmohan Singh and Indresh Srivastava
Lessons Learned from HIV Treatment Interruption: Safety, Correlates of Immune Control, and Drug Sparing
Journal:
Current HIV Research
Volume:
1
Page:
329-342
Author(s):
Livio Azzoni, Emmanouil Papasavvas and Luis J. Montaner
Chromatin Remodeling and Modification during HIV-1 Tat-activated Transcription
Journal:
Current HIV Research
Volume:
1
Page:
343-362
Author(s):
Anne Pumfery, Longwen Deng, Anil Maddukuri, Cynthia de la Fuente, Hong Li, John D. Wade, Paul Lambert, Ajit Kumar and Fatah Kashanchi